Literature DB >> 16893894

Structural and functional evidence for the role of the TLR2 DD loop in TLR1/TLR2 heterodimerization and signaling.

Jitendra K Gautam1, Laurey D Comeau, Joanna K Krueger, Michael F Smith.   

Abstract

The Toll/Interleukin-1 receptor (TIR) domain of the Toll-like receptors (TLRs) plays an important role in innate host defense signaling. The TIR-TIR platform formed by the dimerization of two TLRs promotes homotypic protein-protein interactions with additional cytoplasmic adapter molecules to form an active signaling complex resulting in the expression of pro- and anti-inflammatory cytokine genes. To generate a better understanding of the functional domains of TLR2 we performed a random mutagenesis analysis of the human TLR2 TIR domain and screened for TLR2/1 signaling-deficient mutants. Based upon the random mutagenesis results, we performed an alanine scanning mutagenesis of the TLR2 DD loop and part of the alphaD region. This resulted in the identification of four residues crucial for TLR2/1 signaling: Arg-748, Phe-749, Leu-752, and Arg-753. Computer-assisted energy minimization and docking studies indicated three regions of interaction in the TLR2/1 TIR-docked heterodimer. In Region I, residues Arg-748 and Phe-749 in TLR2 DD loop were involved in close contacts with Gly-676 in the TLR1 BB loop. Because this model suggested that steric hindrance would significantly alter the binding interactions between DD loop of TLR2 and BB loop of TLR1, Gly-676 in TLR1 was rationally mutated to Ala and Leu. As expected, in vitro functional studies involving TLR1 G676A and TLR1 G676L resulted in reduced PAM(3)CSK(4) mediated NF-kappaB activation lending support to the computerized predictions. Additionally, mutation of an amino acid residue (TLR2 Asp-730) in Region II also resulted in decreased activity in agreement with our model, providing new insights into the structure-function relationship of TLR2/1 TIR domains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893894      PMCID: PMC1769446          DOI: 10.1074/jbc.M602057200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

2.  Ligand-receptor docking with the Mining Minima optimizer.

Authors:  L David; R Luo; M K Gilson
Journal:  J Comput Aided Mol Des       Date:  2001-02       Impact factor: 3.686

3.  An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2.

Authors:  Xiao Tao; Yingwu Xu; Ye Zheng; Amer A Beg; Liang Tong
Journal:  Biochem Biophys Res Commun       Date:  2002-11-29       Impact factor: 3.575

4.  Folded conformation of an immunostimulating tetrapeptide rigin: high temperature molecular dynamics simulation study.

Authors:  A Ashish; R Kishore
Journal:  Bioorg Med Chem       Date:  2002-12       Impact factor: 3.641

5.  Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.

Authors:  Y Xu; X Tao; B Shen; T Horng; R Medzhitov; J L Manley; L Tong
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

6.  Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.

Authors:  Virginia S Carl; Kathleen Brown-Steinke; Martin J H Nicklin; Michael F Smith
Journal:  J Biol Chem       Date:  2002-03-04       Impact factor: 5.157

7.  Common interaction surfaces of the toll-like receptor 4 cytoplasmic domain stimulate multiple nuclear targets.

Authors:  Tapani Ronni; Vishal Agarwal; Michael Haykinson; Margaret E Haberland; Genhong Cheng; Stephen T Smale
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 8.  The Toll-IL-1 receptor adaptor family grows to five members.

Authors:  Luke A J O'Neill; Katherine A Fitzgerald; Andrew G Bowie
Journal:  Trends Immunol       Date:  2003-06       Impact factor: 16.687

9.  A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses.

Authors:  Tamas Bartfai; M Margarita Behrens; Svetlana Gaidarova; Janell Pemberton; Alexander Shivanyuk; Julius Rebek
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

10.  Binding specificity of Toll-like receptor cytoplasmic domains.

Authors:  Victoria Brown; Rachel A Brown; Adrian Ozinsky; Jay R Hesselberth; Stanley Fields
Journal:  Eur J Immunol       Date:  2006-03       Impact factor: 5.532

View more
  39 in total

1.  Predicting flexible loop regions that interact with ligands: the challenge of accurate scoring.

Authors:  Matthew L Danielson; Markus A Lill
Journal:  Proteins       Date:  2011-11-09

2.  TIR domain-containing adaptor SARM is a late addition to the ongoing microbe-host dialog.

Authors:  Qing Zhang; Christian M Zmasek; Xiaohui Cai; Adam Godzik
Journal:  Dev Comp Immunol       Date:  2010-11-24       Impact factor: 3.636

Review 3.  Neural injury following stroke: are Toll-like receptors the link between the immune system and the CNS?

Authors:  Catherine E Downes; Peter J Crack
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

4.  Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.

Authors:  Pragnesh Mistry; Michelle H W Laird; Ryan S Schwarz; Shannon Greene; Tristan Dyson; Greg A Snyder; Tsan Sam Xiao; Jay Chauhan; Steven Fletcher; Vladimir Y Toshchakov; Alexander D MacKerell; Stefanie N Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 5.  Arterial Catheterization and Infection: Toll-like Receptors in Defense against Microorganisms and Therapeutic Implications.

Authors:  Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

6.  Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer.

Authors:  Katja Farhat; Sabine Riekenberg; Günther Jung; Karl-Heinz Wiesmüller; Thomas W Jungi; Artur J Ulmer
Journal:  Vet Res       Date:  2010-01-26       Impact factor: 3.683

7.  Inhibition of TLR4 signaling by TRAM-derived decoy peptides in vitro and in vivo.

Authors:  Wenji Piao; Stefanie N Vogel; Vladimir Y Toshchakov
Journal:  J Immunol       Date:  2013-01-23       Impact factor: 5.422

8.  Molecular mimicry in innate immunity: crystal structure of a bacterial TIR domain.

Authors:  Siew Leong Chan; Lieh Yoon Low; Simon Hsu; Sheng Li; Tong Liu; Eugenio Santelli; Gaelle Le Negrate; John C Reed; Virgil L Woods; Jaime Pascual
Journal:  J Biol Chem       Date:  2009-06-17       Impact factor: 5.157

Review 9.  The potential of targeting Toll-like receptor 2 in autoimmune and inflammatory diseases.

Authors:  E M Pålsson-McDermott; L A J O'Neill
Journal:  Ir J Med Sci       Date:  2007-11-15       Impact factor: 1.568

10.  Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection.

Authors:  Mangesh R Bhide; Rastislav Mucha; Ivan Mikula; Lucia Kisova; Rostislav Skrabana; Michal Novak; Ivan Mikula
Journal:  BMC Genet       Date:  2009-05-26       Impact factor: 2.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.